The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review
Open accessAbstract
Neurodevelopmental disorders (NDD s) are defined as a group of disorders caused by changes in early brain development, resulting in behavioral and cognitive alterations in sensory and motor systems, speech, and language. NDD s affect approximately 1–2% of the general population. Up to 80% of children with NDD s are reported to have disrupted sleep; subsequent deleterious effects on daytime behaviors, cognition, growth, and overall development of the child are commonly reported. Examples of NDD s discussed in this review include autism spectrum disorder, cerebral palsy, Rett syndrome, Angelman syndrome, Williams syndrome, and Smith‐Magenis syndrome. The etiology of sleep disorders in children with NDD s is largely heterogeneous and disease specific. The diagnosis and management of sleep disorders in this population are complex, and little high‐quality data exist to guide a consistent approach to therapy. Managing sleep disorders in children with NDD s is critical both for the child and for the family but is often frustrating due to the refractory nature of the problem. Sleep hygiene must be implemented as first‐line therapy; if sleep hygiene alone fails, it should be combined with pharmacologic management. The available evidence for the use of common pharmacologic interventions, such as iron supplementation and melatonin, as well as less common interventions, such as melatonin receptor agonists, clonidine, gabapentin, hypnotics, trazodone, and atypical antipsychotics is reviewed. Further, parents and caregivers should be provided with appropriate education on the nature of the sleep disorders and the expectation for modest pharmacologic benefit, at best. Additional data from well‐designed trials in children with NDD s are desperately needed to gain a better understanding of sleep pharmacotherapy including efficacy and safety implications. Until then, clinicians must rely on the limited available data, as well as clinical expertise, when managing sleep disorders in the population of children with NDD s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sleep hygiene for children with neurodevelopmental disabilities
Jan, J. E., Owens, J. A., Weiss, M. D., Johnson, K. P., Wasdell, M. B., Freeman, R. D., & Ipsiroglu, O. S. (2008) · Pediatrics · doi:10.1542/peds.2007-3308 · Cited by 231
Children with autism: effect of iron supplementation on sleep and ferritin
Dosman, C. F., Brian, J. A., Drmic, I. E., Senthilselvan, A., Harford, M. M., Smith, R. W., Sharieff, W., Zlotkin, S. H., Moldofsky, H., & Roberts, S. W. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2006.11.004 · Cited by 189
Use of clonidine in children with autism spectrum disorders
Ming, X., Gordon, E., Kang, N., & Wagner, G. C. (2008) · Brain and Development · doi:10.1016/j.braindev.2007.12.007 · Cited by 183
Goldman, S. E., Adkins, K. W., Calcutt, M. W., Carter, M. D., Goodpaster, R. L., Wang, L., Shi, Y., Burgess, H. J., Hachey, D. L., & Malow, B. A. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2123-9 · Cited by 133 · cited 1×
“deficiency and may include other mechanisms of action such as additive hypnotic effects, circadian rhythm shifting, and effects on anxiety.(33) In a 4-week, crossover trial, the efficacy and safety of melatonin (analytical grade, Regis Chemical Company, Morton Grove, IL) were evaluated in nine female children with Ret…”
BackgroundDe Leersnyder, H., de Blois, M.-C., Vekemans, M., Sidi, D., Villain, E., Kindermans, C., & Munnich, A. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.9.586 · Cited by 113
Abnormal circadian rhythm of melatonin in Smith–Magenis syndrome patients with RAI1 point mutations
Boone, P. M., Reiter, R. J., Glaze, D. G., Tan, D., Lupski, J. R., & Potocki, L. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34098 · Cited by 47
Cited by
Identification, Evaluation, and Management of Children With Autism Spectrum Disorder
Hyman, S. L., Levy, S. E., Myers, S. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Kuo, D. Z., Apkon, S., Davidson, L. F., Ellerbeck, K. A., Foster, J. E. A., Noritz, G. H., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3447 · Cited by 1,798
Melatonin as a Hormone: New Physiological and Clinical Insights
Cipolla-Neto, J., & Amaral, F. G. D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00084 · Cited by 635
Morgan, C., Fetters, L., Adde, L., Badawi, N., Bancale, A., Boyd, R. N., Chorna, O., Cioni, G., Damiano, D. L., Darrah, J., et al. (2021) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2021.0878 · Cited by 461
Clinical Assessment, Genetics, and Treatment Approaches in Autism Spectrum Disorder (ASD)
Genovese, A., & Butler, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134726 · Cited by 268
Muskens, J. B., Velders, F. P., & Staal, W. G. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1020-0 · Cited by 232
Metadata
- Authors
- Blackmer, A. B., & Feinstein, J. A.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2016-01
- Volume
- 36
- Issue
- 1
- Pages
- 84-98
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W2268019454
- Cited by
- 237
- References
- 6
- FWCI
- 24.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.